INVIVO THERAPEUTICS HOLDINGS CORP. Quarterly Other Liabilities, Noncurrent in USD from Q4 2017 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
Invivo Therapeutics Holdings Corp. quarterly Other Liabilities, Noncurrent history and growth rate from Q4 2017 to Q2 2023.
  • Invivo Therapeutics Holdings Corp. Other Liabilities, Noncurrent for the quarter ending June 30, 2023 was $109K, a 14.7% increase year-over-year.
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $109K +$14K +14.7% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $109K +$14K +14.7% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $103K +$9K +9.57% Dec 31, 2022 10-Q 2023-11-08
Q3 2022 $102K +$13K +14.6% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $95K +$18K +23.4% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $95K +$16K +20.3% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $94K +$35K +59.3% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $89K +$30K +50.8% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $77K +$18K +30.5% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $79K +$20K +33.9% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $59K $0 0% Dec 31, 2020 10-K 2022-03-07
Q3 2020 $59K -$4K -6.35% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $59K -$4K -6.35% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $59K -$3K -4.84% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $59K -$2K -3.28% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $63K +$7K +12.5% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $63K +$4K +6.78% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $62K +$4K +6.9% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $61K +$5K +8.93% Dec 31, 2018 10-K 2020-02-20
Q3 2018 $56K Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $59K Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $58K Mar 31, 2018 10-Q 2018-05-07
Q4 2017 $56K Dec 31, 2017 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.